Novel Inhibitors of MLLT1/3, a Critical Component of the Super-Elongation Complex (SEC), Target a Range of Molecularly Defined Acute Leukemias, with a Differential Profile to Menin Inhibition
Pollard J., Craggs G., Farnie G., Fawkes M., Fedorov O., Giroud C., Gross F., Harman J., Maloney A., Milne TA., Simpson I.